BlackRock Institutional Trust’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

BlackRock Institutional Trust’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$757K	Sell	145,577 -7,475	-5%	-$35.1K	﹤0.01%	3366
2016 Q3	$715K	Hold	153,052	–	–	﹤0.01%	3398
2016 Q2	$603K	Buy	153,052 +3,613	+2%	+$13.5K	﹤0.01%	3459
2016 Q1	$463K	Hold	149,439	–	–	﹤0.01%	3475
2015 Q4	$683K	Buy	149,439 +61,122	+69%	+$290K	﹤0.01%	3428
2015 Q3	$416K	Buy	88,317 +16,272	+23%	+$105K	﹤0.01%	3535
2015 Q2	$516K	Sell	72,045 -153,429	-68%	-$1.15M	﹤0.01%	3501
2015 Q1	$1.91M	Sell	225,474 -414	-0.2%	-$3.53K	﹤0.01%	3139
2014 Q4	$2.1M	Sell	225,888 -5,416	-2%	-$47.1K	﹤0.01%	3074
2014 Q3	$1.93M	Sell	231,304 -13,514	-6%	-$125K	﹤0.01%	3093
2014 Q2	$2.83M	Buy	244,818 +31,174	+15%	+$320K	﹤0.01%	3035
2014 Q1	$2.71M	Buy	213,644 +79,782	+60%	+$1.03M	﹤0.01%	3039
2013 Q4	$1.45M	Sell	133,862 -16,580	-11%	-$193K	﹤0.01%	3273
2013 Q3	$1.86M	Buy	150,442 +7,426	+5%	+$103K	﹤0.01%	3162
2013 Q2	$1.91M	Buy	+143,016	New	+$1.84M	﹤0.01%	3097

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock Institutional Trust's DSCI Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Derma Sciences, Inc. Common Stock (DE) (DSCI) stake by 4.9% in Q4 2016, selling an estimated $35.1K and leaving 145,577 shares worth $757K. The position accounts for ﹤0.01% of the portfolio, ranked #3366.

BlackRock Institutional Trust first reported a position in DSCI in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.83M in Q2 2014. 52 funds tracked by Wall St. Rank hold DSCI as of Q4 2016.

BlackRock Institutional Trust held 145,577 shares of Derma Sciences, Inc. Common Stock (DE) worth $757K as of Q4 2016.
BlackRock Institutional Trust sold 7,475 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2016, an estimated $35.1K.
Derma Sciences, Inc. Common Stock (DE) made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3366 holding.
BlackRock Institutional Trust first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Derma Sciences, Inc. Common Stock (DE) position peaked at $2.83M in Q2 2014.
52 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.